Neuropace, Inc. NPCE Total Operating Expenses
Total Operating Expenses at other companies
Other financials
Where this comes from
Reported directly by Neuropace, Inc. in its filing.
Tagged under the XBRL concept us-gaap:OperatingExpenses.
The official record: Neuropace, Inc.’s 10-Q, filed May 12, 2026, on SEC EDGAR. View the filing →
Ask your AI about Neuropace, Inc.'s total operating expenses.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Neuropace, Inc.'s total operating expenses?
- Neuropace, Inc. (NPCE) reported total operating expenses of $23.62M in Q1 2026.
- How has Neuropace, Inc.'s total operating expenses changed year-over-year?
- Neuropace, Inc.'s total operating expenses increased by 5.0% year-over-year, from $22.49M to $23.62M.
- What is the long-term trend for Neuropace, Inc.'s total operating expenses?
- Over 4 years (2021 to 2025), Neuropace, Inc.'s total operating expenses has grown at a 13.1% compound annual growth rate (CAGR), from $57.17M to $93.56M.
- What does total operating expenses mean?
- The sum of all operating costs including COGS, SG&A, R&D, D&A, and other operating charges. Revenue minus total operating expenses equals operating income.